Articles

Vaccines for human viral diseases are among the most successful inventions in medical history: smallpox was declared extinguished in 1980, and poliomyelitis is nearing global eradication. New vaccines employing biotech innovations are changing the way we prevent illness. However,...

When to Start Creating Your Secondary Packaging Strategy Pharmaceutical and biotechnology companies with a drug product in clinical development are usually focused on a quick commercial launch. Secondary packaging aspects are often less considered. Correlations with secondary packaging (in this...

Pharma is at the cusp of third industrial revolution. The first occurred in the late 18th century with the move from agrarian and handicraft-based societies to machine manufacturing. The second occurred in the early 20th century when companies could...

Over the past decade there has been significant hype surrounding blockchain – particularly in the financial services sector and around its role in cryptocurrencies. We are now seeing the conversation progress as new applications of the technology appear. In...

The landscape for clinical trials has seemingly been turned upside down with the onset of the COVID-19 pandemic. However, there is one factor that has remained crucial, and that is “patient centricity.” This term- patient centricity,has been talked about...

As biopharmaceutical companies focus tirelessly on developing a vaccine for the COVID-19 virus, they are expected to both rapidly develop vaccines and then scale up into mass production. In order to achieve to these goals, they must have access...

Treatments for diseases of all types are important. Treatments for a disease that is central to a global pandemic are beyond important. We are finally seeing major progress for vaccines to prevent the spread of COVID-19 ( https://www.worldpharmatoday.com/news/pfizer-and-biontech-aim-to-start-testing-coronavirus-vaccines-in-humans-by-late-april/ )....